Cochlear implants restore hearing cues in the severe-profoundly deaf by electrically stimulating spiral ganglion neurons (SGNs).
Introduction
In the normal hearing cochlea, hair cells within the organ of Corti induce action potentials in the primary afferent neurons of the auditory nerve (spiral ganglion neurons; SGNs) in response to micro-mechanical acoustic stimulation. In patients with a severe-profound hearing loss, most commonly caused by loss of hair cells, a cochlear implant is the only therapeutic option available, providing auditory cues by electrically stimulating SGNs. However, the loss of hair cells initiates a gradual degeneration of SGNs which is observed in both animal models of deafness (Spoendlin, 1984; Leake and Hradek, 1988; Hardie and Shepherd, 1999; Dodson and Mohuiddin, 2000) and in human cochleae (Nadol et al., 1989; Zimmermann et al., 1995; Nadol, 1997; Miura et al., 2002) . This SGN degeneration is due, at least in part, to the loss of the endogenous source of the neurotrophin (NT) peptides brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) resulting in apoptotic cell death (Alam et al., 2007) . These NTs are normally expressed by hair cells (Ylikoski et al., 1993; Ernfors et al., 1995; Tan and Shepherd, 2006; Sugawara et al., 2007) and support cells (Stankovic et al., 2004; Zilberstein et al., 2012) of the organ of Corti.
Administering exogenous NTs to deafened cochleae rescues SGNs from these degenerative changes (Miller et al., 1997; Shinohara et al., 2002; Gillespie et al., 2003; Richardson et al., 2005; Shepherd et al., 2005; Agterberg et al., 2008; Glueckert et al., 2008; Wise et al., 2011) . Associated with this rescue effect is a proliferation in the number of peripheral SGN neurites compared to deafened controls (Wise et al., 2005; Leake et al., 2011) . Moreover, in contrast with the highly radial neurite projections observed in normal cochleae, SGNs treated with exogenous NTs often exhibit ectopic neurite growth (Staecker et al., 1996; Wise et al., 2005; Glueckert et al., 2008; Leake et al., 2011) .
In the normal cochlea SGN neurites innervating inner hair cells (IHC) are spatially arranged along the cochlea in a precise radial path as they project from their soma (Spoendlin, 1969; Liberman, 1982; Bohne and Harding, 1992) . The frequency-specific activation of hair cells to acoustic stimulation at spatially restricted cochlear locations leads to activation of localized SGN populations resulting in a precise tonotopic map. Cochlear implants take advantage of this spatial organization by stimulating different cochlear locations to produce different pitch percepts based on electrode position (Tong et al., 1982; Shannon, 1983) . Disruption to SGNs and their neurites as a result of disease and/or therapeutic treatment may result in an increase in the extent of spatial activation of SGNs to intracochlear electrical stimulation (ES), reducing electrode pitch discriminability in implant recipients and leading to reduced speech perception (Henry et al., 2000) . Therefore, while producing a number of potentially beneficial effects, such as reduced thresholds to ES (Shinohara et al., 2002; Shepherd et al., 2005; Leake et al., 2011) , exogenous NT treatment may have the unintended consequence of degrading speech perception in implant patients by inducing disorganized SGN neurite growth.
We measured the extent of the ectopic growth of SGN neurites and the spread of neural activation to intracochlear electrical stimulation in deafened guinea pigs following chronic NT and/or ES treatment. We have previously reported a significant rescue effect of SGNs in the same NT treated cochleae, associated with a significant reduction in the auditory brainstem response threshold to ES (Landry et al., 2011) . In the present study we report that chronic NT delivery also evokes a significant increase in the extent of neurite growth at the cochlear periphery. Importantly, these changes did not result in an increase in the spread of excitation to intracochlear ES.
Materials and Methods
Experimental animals. Twenty-six (N = 26) young adult pigmented guinea pigs (300-600 g) of either sex were used. Table 1 summarizes the five cohorts in the study. The treatment procedures are described in detail elsewhere (Landry et al., 2011) . Prior to experimental use, all animals were otoscopically normal and had normal hearing thresholds as measured by auditory brainstem responses (ABR) to acoustic clicks (Landry et al., 2011) . All procedures were approved by the Royal Victorian Eye and Ear Hospital Animal Research Ethics Committee.
Deafening, cochlear implantation and chronic stimulation. Guinea pigs were ototoxically deafened by an intravenous injection of frusemide (130 mg/kg; Ilium, Australia), followed by a subcutaneous injection of kanamycin sulfate (420 mg/kg; Sigma-Aldrich, USA) within 2 minutes of frusemide administration . Animal weight and behavior were closely monitored for the week following aminoglycoside treatment. After two weeks of recovery each animal was anesthetized with ketamine (60 mg/kg; Parnell, Australia) and xylazine (4mg/kg, intramuscular; Ilium, Australia), and severe hearing loss was confirmed by an increase of > 50 dB in ABR thresholds to acoustic clicks. The degeneration of the organ of Corti was also observed histologically following sacrifice (Landry et al., 2011) . Under aseptic conditions, the left cochlea was then surgically exposed, the round window opened and an electrode array inserted 6 mm into the lower basal turn scala tympani (ST) (Fig. 1a&b) . The design of the implant was a modified version of Shepherd and Xu (2002) . Briefly, each electrode array included six platinum ring electrodes (0.2 mm wide; 0.4 mm diameter; 0.3 mm inter-electrode spacing). Electrodes were numbered from E1 at the apical end to E6 at the basal end. All implants contained a drug delivery cannula that was attached to an osmotic pump (200 µL capacity; 28 day delivery period; 0.25 µL/hr; Alzet, USA) containing artificial perilymph (AP) or NTs (30 µg/mL each of BDNF and NT-3; human recombinant; PeproTech, USA) dissolved in AP. Osmotic pumps were surgically positioned subcutaneously between the scapulae. The electrode array lead was fixed to the temporal bone with dental cement and exited the skin via a percutaneous connector . Electrically-evoked ABR thresholds were then determined for ES across all bipolar electrode combinations (bipolar electrode separations are given as BP+x, where x is the number of inactive electrode rings between the anode and cathode). Five days after implantation the ES cohorts commenced their chronic stimulation program by connecting the percutaneous connector to commercial cochlear implant stimulus generation hardware (CI22 stimulator and ESPrit 3G speech processor; Cochlear, Australia) placed in a backpack worn by the animal (Fallon et al., 2009) . Chronic ES was delivered sequentially to three bipolar pairs (E1-2, E3-4, and E5-6). Stimuli consisted of charge-balanced biphasic current pulses (100 µs phase duration, 50 µs interphase gap) presented at 1200 pulses per second (pps) per channel (total rate 3600 pps) continuously over a 28 day treatment period. Stimulus intensity was programmed to be in the range -3 to +6 dB (re: electrically-evoked ABR threshold) per channel (Fallon et al., 2009 ). An additional two cohorts received NT or AP without receiving ES (unstimulated [US] cohorts in Table 1 ).
Recording from the inferior colliculus. Following the 28 day treatment period, an acute terminal experiment was performed to record multi-unit neural activity in the IC to intracochlear ES (Snyder et al., 2004) and to apply a retrograde neural tracer to the trunk of the auditory nerve (AN) in order to trace individual SGN neurites.
Guinea pigs were anesthetized as described above and body temperature was maintained at 37 o C with a heat pad. The head was placed in a stereotaxic frame and the IC contralateral to the implanted cochlea was exposed. Neural activity was recorded using a 32-channel single shank silicon substrate electrode array (NeuroNexus Technologies, USA) with electrode spacing of 100 µm center-to-center and impedances of 1-1.5 MΩ. The array was mounted on a micromanipulator (2662 Micropositioner; Kopf, USA) and advanced across the cochleotopic axis of the central nucleus of the IC (ICC) at 45° from the midline (Martin et al., 1988) . Fluorescent dye was deposited on the recording array in order to verify its location within the ICC histologically (Lim and Anderson, 2007) .
Single and multi-unit activity was recorded simultaneously from the 32 channels in response to intracochlear ES using a Cerebus recording system (Blackrock Microsystems, USA) at a sampling frequency of 30 kHz per channel. The signal was digitally band-pass filtered (0.25-7.50 kHz), and the spike detection threshold was set at a voltage between −3.75 and −4.0 times the root mean square of the noise floor for each channel in order to detect spike activity above the noise floor.
Input/output functions were determined across all IC recording sites for each stimulating electrode pair using bipolar ES (parameters identical to the chronic ES program). Stimuli were delivered in a randomized fashion over a range of 0-2 mA in 25 µA steps (or to 50 µA below the threshold for stimulus-induced muscle activation) at a rate of 5 pps for 20 repetitions.
In normal hearing controls the head was secured with hollow ear bars to allow for closed-field acoustic stimulation. The IC was exposed and a recording array inserted as described above. Using in-house designed software, pure tone bursts (50 ms duration; 1 ms linear rise/fall) were generated with randomly varying frequency (0.625-10 kHz at 2/octave, and 10-40 kHz at 4/octave) and intensity (0-80 dB SPL, in 5 dB steps) for 20 repetitions. Acoustic stimuli were delivered via a Tucker Davis Technologies (USA) Series II D/A converter (200 kHz sampling) and Vifa XT25TG-30-04 tweeter speaker (Speakerbits, Australia). Following multichannel recording of IC responses to acoustic stimulation, the left cochlea was surgically exposed and acutely deafened by perfusing the ST with 10% neomycin sulfate in order to prevent electrical activation of hair cells (Black et al., 1983) . A cochlear electrode array was then acutely implanted and IC responses to ES were recorded.
Auditory nerve tracing.
Following the completion of IC recordings, the left AN trunk exiting the internal auditory meatus was exposed using a dorsoventral approach (Evans, 1972) . A quartz glass micropipette (P-2000 model pipette puller; Sutter Instruments, USA) with a tip diameter of 20-25 µm was front-filled with 5 µL of 15% biotinylated dextran amine (BDA; 3 kD; lysine-fixable; Invitrogen, USA) in 0.1 M sodium-citrate-HCl (pH = 3.0) (Reiner et al., 2000) .
The micropipette was advanced through the AN at a rate of 10 µm/s using a micromanipulator while the tracer was pressure injected using a PV830 pneumatic pump (World Precision Instruments, USA) at 20 psi in 10 ms pulses (~20 nL per pulse) at 2 pps. The pipette was advanced 1.5 mm, the injection was stopped, and the pipette left in place for 10 min before being withdrawn. The exposure was flushed with saline and then the injection protocol was repeated at a second AN location.
After allowing 3 hours for the tracer to diffuse within the SGNs, each animal was overdosed with sodium pentobarbital (150 mg/kg; i.p.), transcardially perfused with 0.9% NaCl (37° C) followed by 4% paraformaldehyde in 0.1 M phosphatebuffered saline (4° C, pH = 7.35). The cochleae were isolated, post-fixed overnight in 4% paraformaldehyde (4° C) then placed in ethylenediamine tetraacetic acid in phosphate-buffed saline at room temperature for a period of two weeks to complete decalcification. The midbrain was isolated and sectioned at 80 µm in the coronal plane using a vibrating microtome, and stained with thionin for verification of recording array placement within the ICC.
Cochlear histology. The lower basal turn of each cochlea adjacent to the electrode array was prepared for histological examination using surface preparation techniques and immunolabeled for neurofilament (NF200; 200 kD) as a tissue marker for SGNs and their peripheral neurites (Wise et al., 2005; . Briefly, tissue was incubated in 2% goat serum, followed by anti-NF200 polyclonal rabbit antibodies (1:400; Sigma-Aldrich, N4142, USA) for 48 h, and finally with anti-rabbit goat antibodies (1:200; Alexa-488-conjugated; SigmaAldrich, USA) and NeutrAvidin (0.033 mg/mL; tetramethylrhodamine conjugated; Invitrogen, USA) for 2 h to label NF200 and BDA, respectively. The preparations were then mounted on slides with 100% glycerol. Several measurements were made from the traced neurites to quantify the extent of ectopic growth (Fig. 2) . First, the degree of lateral deviation of each neurite was determined by measuring the sum of its greatest deviation in both the basal and apical directions relative to a radial axis. Second, the length of the neurite was measured from the HP. Finally, to determine whether ES or NT treatments provided significant guidance cues, the distance from the HP to the tip of the neurite was divided by its total length ("directionality"; The number of spikes detected was averaged across trials for each stimulus condition at each recording location. Each datum was normalized between the spontaneous activity rate and maximum response for any stimulating electrode according to the formula:
where RN i is the normalized value for a given stimulus at the ith recording electrode, R i is the average spike count, S i is the spontaneous firing rate (average rate in a 33-3 ms pre-stimulus window prior to all stimuli), and M i is the maximum firing rate recorded at each recording location for any stimulus. The data were also smoothed across the matrix with a 3×3 Gaussian function (normalization and smoothing functions from Snyder et al., 2008) .
Threshold (defined as a response 30% above the spontaneous activity) was determined for each of the 32 recording sites across the IC (see Fig. 4b for a 10 kHz acoustic stimulus). This definition of threshold is consistent with previously published work (Snyder et al., 2008) . Thresholds at 30% above spontaneous activity follow the boundary of the response images and capture the broader activation seen with more widely spaced bipolar pairs. While a lower percentage or a threshold measure based on d' might give a wider extent of activation, this would be true across all conditions, and therefore would be unlikely to affect the group comparisons. Mean first spike latency and jitter [standard error of the mean (SEM) of latency] were also examined across recording sites. Response intensity data are displayed across the IC as "spatial response images" -juxtaposed input/output data for each of the 32 IC recording sites -revealing the spread of activation across the IC for either acoustic or electrical stimuli (e.g. Fig.   4d&f ). Finally, to determine the spread of neural activation across the IC, a spatial tuning curve (STC) was produced at threshold for each ES electrode, and the STC widths were measured at 1 to 6 dB above threshold as a measure of the spread of activation across stimulus amplitudes. Neurites from the normal animals were typically short (~10 µm from the HP), radial, and terminated at the level of the closest IHC. In contrast, neurites across all deafened treatment groups exhibited greater variability in length and an increase in deviation from a radial projection compared with the normal controls.
Results

Analysis
Cochleae treated with ES/NT showed the most ectopic growth patterns. In the few instances where labeled neurites were able to be visualized within the osseous spiral lamina (OSL), their projection profiles were typically similar to that observed in normal cochleae although evidence of an ectopic projection was occasionally observed (Fig.2a) .
The group data are shown in Figure 3 . The length and lateral deviation data were not normally distributed, therefore statistical comparisons were performed using rank transformations of these data (normal cohort excluded from ranking).
In two-way ANOVAs (AP-NT, US-ES factors), NT treated animals showed a significant increase in neurite length (F [df error 145] = 7.654, p = 0.006) and lateral deviation (F = 13.943, p < 0.0005), and a decrease in directionality (F = 11.278, p = 0.001) compared to animals treated with AP. Significantly greater neurite length was also seen in ES animals compared to US (F = 6.385, p = 0.013). All other main effects and interactions were not statistically significant (p > 0.05).
Directionality of neurites appeared to be quite high in ES/AP compared to other treatment groups despite no significant interactions, but an a posteriori independent samples t-test between US/AP and ES/AP directionality rank means confirmed no significant difference (p > 0.05). To determine the effects of longterm deafening and cochlear implantation without ES or NT treatment, independent samples t-tests were performed between US/AP and normal controls, with significant differences for neurite length (t = −7.060), lateral deviation (t = −4.359) and directionality (t [df 113] = 3.909; p < 0.0005 for each measure).
The majority (83%) of neurites projected from the HP towards the basilar membrane, whereas a small proportion projected in the opposite direction (i.e. towards the spiral limbus; Fig. 2 ). Neurites were also occasionally observed within the ST; most contained a bulbous structure at the tip of the neurite.
Inferior colliculus recordings. Neural responses to ES were recorded across the cochleotopically organized ICC to examine the effects of ectopic neurite growth on the spread of SGN activation. Histological examination of the IC verified that the recording array was optimally located in the ICC in all but one animal (data not shown). Data from this normal control animal were excluded, giving the following animal numbers per cohort: normal n = 4, US/AP n = 6, US/NT n = 5, ES/AP n = 4, ES/NT n = 6. Figure 4a illustrates typical multiunit activity recorded at individual recording site across the ICC in a normal hearing animal to acoustic stimulation. Two IC regions with low threshold to a given frequency were seen (e.g. Fig. 4d ), corresponding to the ICC and the external nucleus of the IC (ICX).
Basic response properties.
Fine frequency tuning, characteristic of the ICC, is evident within individual ICC locations (e.g. Fig. 4b ), while fine spatial tuning to pure tones can be seen across the ICC (Fig. 4d) . The characteristic frequency (CF) varied systematically across the ICC, with lower CFs dorsolaterally and higher CFs ventromedially (Fig. 4c) .
Electrically-evoked ICC activity exhibited mean first spike latencies in the range 3.6-6.0 ms. Response thresholds (0.30 normalized response intensity) were examined for BP+0 (adjacent bipolar) stimulating electrodes for the "best recording location" (i.e. the ICC location with the lowest threshold). A repeated measures ANOVA showed no significant effect of BP+0 configuration on threshold across all animals (p > 0.05), indicating that E1-2, E2-3, E3-4, and E4-5 yielded similar thresholds within animals (data for the bipolar electrode pair E5-6 were typically excluded as responses evoked by these electrodes were often contaminated by myogenic activity). The mean best location threshold for BP+0 electrodes was calculated for each animal, and treatment group means were compared with a two-way ANOVA (AP-NT, US-ES factors; normals excluded; Table 2 ). Significantly higher thresholds were found for ES animals compared to Fig 5b) .
Because BP+0 electrodes produce the most spatially restricted ICC STCs (Fig.   5a ), data generated from this stimulating electrode geometry were examined for variation in the spread of activation across treatment groups. The STC width for all groups increased with increasing stimulus intensity and the rate of increase was similar across the cohorts (Fig. 6) . The two ES treated cohorts (ES/AP and ES/NT) showed greater STC widths compared to US cohorts (US/AP and US/NT) and normal animals. To compare the groups statistically, two-way ANOVAs were performed (US-ES and AP-NT factors) on the mean BP+0 (E1-2, E2-3, E3-4) STC widths at 1, 2, 4, and 6 dB above threshold. To correct for the multiple comparisons, type I error rate of 0.05 was adjusted to 0.0125 for these tests.
Although we observed a significant increase in BP+0 STC width in ES treated animals compared to US animals at 1 dB (F [df error 17] = 27.305, p < 0.0005) and 2 dB above threshold (F = 15.989, p = 0.001), there was no significant effect of NT or treatment interaction at any stimulus level tested. Independent samples ttests between US/AP and normal controls showed no significant difference at 1, 2, 4, or 6 dB above threshold.
Relationship between spread of activation and threshold. ES animals had both significantly higher ICC thresholds and significantly broader STCs than US animals at 1 and 2 dB above threshold. ICC threshold and STC width data were examined together to determine if there was a significant relationship between the two measures. Figure 7 shows the within-animal mean threshold for E1-2, E2-3, and E3-4 plotted against the mean STC width at 2 dB above threshold for the same cochlear electrodes. Lower electrical thresholds were statistically correlated with narrower STC widths (Pearson's correlation, r 2 = 0.311, p = 0.004). To investigate whether this SGN survival was a factor in this observation, data from normal animals were examined (Fig 7b) . Normal controls were chosen because there was much less variability in the SGN density of this cohort compared with the treatment groups (Landry et al., 2011) . A significant correlation was evident across BP+0 electrodes within the normal cohort (E1-2, E2-3, E3-4) (r 2 = 0.482, p = 0.018; Fig 7b) , indicating that the correlation seen in deafened cohorts was not dependent on SGN survival.
Discussion
We have demonstrated that exogenous NT delivery in deafened cochleae that results in significant rescue of SGNs and a concomitant reduction in EABR thresholds, (Landry et al., 2011) will also promote significant ectopic growth of SGN neurites. Importantly, these anatomical changes do not affect the extent of spatial activation of SGNs to ES as measured by spatial tuning curves recorded in the auditory midbrain.
Ectopic peripheral neurite growth.
Previous studies have examined the morphological response of SGN neurites following noise induced hearing loss (Bohne and Harding, 1992) or chemical deafening combined with exogenous NT 21 treatment (Wise et al., 2005; Shibata et al., 2010; Leake et al., 2011; Wise et al., 2011) . Some of the projection patterns described in these studies, including neurite projection towards the spiral limbus, were also observed in the present study. However, few studies have quantified neurite growth patterns in both deafened and chronic NT/ES treated animals (Leake et al., 2011; Wise et al., 2011) .
We hypothesized that a significant increase in lateral deviation associated with chronic NT treatment would disrupt the cochleotopic organization of SGNs to ES via a multichannel electrode array located within the scala tympani. However, the extent of the lateral deviation observed following a one month treatment with NT was small (typically < 100 m) compared to the dimensions of the typical electrodes used in contemporary cochlear implants (see Fig.1d where ectopic neurite growth and an individual platinum electrode are drawn to scale). Given these large differences in dimensions, it is not surprising that there was no significant relationship between chronic NT treatment and the spread of activation to intracochlear ES. It is important to note, however, that longer periods of chronic NT delivery, or treatment in other species/etiologies, may yield more extensive ectopic projections that could result in altered spatial excitation patterns.
We reported similar resprouting of SGN neurites in a previous study of deafened guinea pigs after intracochlear delivery of the same NTs over the same duration (28 days) -but using a higher NT concentration of 50 g/ml (vs. 30 g/ml in the present study) (Wise et al., 2005) . Some neurites looped back upon themselves within the osseous spiral lamina while others meandered along the basilar membrane and form a disorganized tangle of processes. Similar ectopic projection patterns were observed in the present study despite slightly lower NT concentrations and different neurite labelling techniques (Fig 2a) .
While ectopic neurite growth in the present study and Wise et al 2005 were associated with high concentrations of exogenous NT delivered via osmotic pumps, neurite growth was also evident in studies using cell-based techniques where the quantity of NT delivered is expected to at physiological levels (Shibata et al., 2010; Wise et al., 2010; Wise et al., 2011) . In long-term deafened cats, neurites were observed to project into both the cellular epithelial layer on the inner sulcus and the scala tympani . Given the similar response of SGN neurites over such a wide dose range it is reasonable to expect ectopic neurite growth associated with the delivery of NT into the human cochlea irrespective of the delivery technique.
The present study did not address the long-term survival of SGN neurites following removal of their exogenous NT source. Given the retraction of neurites following loss of hair cells and supporting cells in the normal organ of Corti (i.e.
their endogenous source of NT), and evidence of a loss of SGNs following the withdrawal of their exogenous NT source in deafened cochleae (Gillespie et al., 2003) , there is an expectation of a significant retraction. However, there is evidence that chronic ES provides effective protection to SGNs following removal of NT (Shepherd et al., 2008) , although that study did not directly evaluate longterm neurite survival.
Based upon analysis of the neurite directionality data, neither NT nor ES treatment provided any significant guidance cues. While SGN neurites have been shown to navigate towards localized NT sources in vitro (Wittig et al., 2005) and in vivo (Shibata et al., 2010; Wise et al., 2010) , NT delivery via an osmotic pump, as used in the present study, presumably exhibits a minimal concentration gradient due to a rapid and widespread diffusion of the NT throughout the ST (Richardson et al., 2004; Plontke et al., 2007) .
Although rare, we occasionally observed SGN neurites projecting across the OSL wall into the ST. Similar observations have been reported by others (Staecker et al., 1996; Glueckert et al., 2008; Leake et al., 2008; Leake et al., 2011; . The OSL bone is thin and contains micropores [canaliculi perforantes; (Lim and Kim, 1983; Shepherd and Colreavy, 2004) ], through which neurites may project. It is also possible that neurites enter the ST following a localized fracture of the OSL that can occur during the insertion of an electrode array. Many of the neurites projecting into the ST, as well as a small number that projected onto the basilar membrane, had a swelling at the tip reminiscent of a growth cone, although this could also be caused by an abnormality in the structural protein matrix of the neurites. It is unclear what prompts neurites to project into the ST, but they almost always appeared to do so through the OSL wall adjacent to the HP. Moreover, neurites within the ST are often associated with a fibrous tissue matrix (Leake et al., 2011; Wise et al., 2011) , which could provide both physical and chemical support. There would be a number of functional advantages if the growth of neurites into the ST could be routinely promoted and directed towards the proximal electrode. Although there have been some attempts to develop stimulating electrodes that release neural guidance molecules -including NTsto attract neurites, this work is in its infancy (Thompson et al., 2010) .
Reduced thresholds associated with neurotrophin treatment. A significant reduction in the threshold of the electrically-evoked auditory brainstem response
has been reported by a number of studies following chronic NT delivery to deaf cochleae (Shinohara et al., 2002; Shepherd et al., 2005; Landry et al., 2011; Leake et al., 2011) . These results are consistent with the reduced ICC thresholds observed in the present study. Reduced thresholds may be caused by morphological changes in the SGN, such as increased diameter of neurites (Wise et al., 2005; Leake et al., 2011) and/or SGN soma Agterberg et al., 2008; Glueckert et al., 2008; Landry et al., 2011; Leake et al., 2011) , resulting in lower activation thresholds (McNeal, 1976) . Changes in gene expression (e.g. voltage-gated ion channels) associated with NT treatment may also contribute to reduced electrical thresholds. For example, NT-3 and BDNF were shown to induce changes in the expression of several Ca 2+ and voltagegated potassium receptors in SGNs in vitro (Adamson et al., 2002) .
Factors affecting spread of inferior colliculus activation.
The spread of ICC activation was found to be associated with threshold, in agreement with a previous study in neonatally deafened and chronically stimulated cats (Moore et al., 2002) . However, the threshold decreases caused by NT treatment in the present study did not result in corresponding decreases in STC width, suggesting that changes in threshold per se do not affect spatial selectivity of ES, and that some other factor was responsible. Given that this correlation was also found within the normal control group, which had similar SGN density across the cohort (Landry et al., 2011) , it is probable that variation in the location of implant electrodes within the ST, which has a significant effect upon activation threshold (Shepherd et al., 1993) , was a contributing factor. The location of the electrode array relative to the neural elements can vary not only between animals, but also between different implant electrodes within animals due to the large and tapered nature of the ST in the guinea pig basal turn (Thorne et al., 1999) . Positioning electrodes closer to the SGNs is improves the spatial selectivity of intracochlear ES (Frijns et al., 2001) In contrast to chronic NT treatment, we reported that the spread of neural activation within the ICC was significantly increased following chronic ES. Similar effects have also been described by others (Snyder et al., 1990; Leake et al., 2000; Moore et al., 2002; Vollmer et al., 2007) , although the mechanism(s)
underlying this increased spread of activation is unclear. The increase in spread of ICC activation could potentially be a result of changes in one of a number of sites within the auditory pathway. Increased tissue growth within the cochlea following cochlear implantation and ES will result in altered current pathways that may produce broader excitation of SGNs, although we have seen no evidence that ES per se would evoke a greater tissue response than a chronically implanted US electrode array. Changes in excitatory/inhibitory synaptic mechanisms associated with deafness and/or cochlear implantation are known to occur within the various nuclei of the auditory brainstem (Ryugo et al., 2005; Ryugo et al., 2010; Tirko and Ryugo, 2012) . For example, aged-related hearing loss is known to result in changes in pre-and postsynaptic GABAergic and glycinergic inhibitory neurotransmission within the central auditory pathway (Caspary et al., 2008) . While alterations in the balance of excitatory and inhibitory activity could result in increased spread of excitation within the ICC, evidence suggests that intracochlear ES reverses these deafness related changes (Argence et al., 2008; Tirko and Ryugo, 2012) , therefore minimizing the potential spread of activation. Importantly, there is no evidence that there is a reduction in spatial selectivity with cochlear implant use over time in a clinical setting, moreover patient performance using these devices improves with device use (Blamey et al., 1996) .
Clinical implications. The application of exogenous NTs to the deafened cochlea combined with chronic ES has the potential to improve the clinical outcome for implant patients compared to ES alone. Decreased thresholds to ES observed here and elsewhere (Shinohara et al., 2002; Shepherd et al., 2005; Landry et al., 2011; Leake et al., 2011) suggest that NT treatment can reduce power consumption of cochlear implants and allow the development of smaller intracochlear electrodes while still operating within safe charge density limits.
The potentially negative impact of NT-enhanced neurite growth on the spatial selectivity of cochlear implants appears to be negligible, although it remains unclear whether more extensive ectopic growth of neurites would occur with longer treatment periods.
Clinically relevant techniques must be developed for safe long-term NT delivery to the cochlea. A major limitation associated with a pump/cannula based system as used in the present study would be the risk of infection spreading from the pump/delivery system directly into the cochlea (Gillespie and Shepherd, 2005; Shepherd et al., 2005; Leake et al., 2011) . Alternative strategies include the use of viral vectors (Stover et al., 2000; Kanzaki et al., 2002; Wise et al., 2010) ; encapsulated cell-based therapies using either naturally occurring or genetically modified Zanin et al., 2012 ) cells designed express NTs; or biodegradable nonporous particles tuned for gradual NT release (Tan et al., 2012) . The effects of long-term NT treatment using any of these delivery vehicles on both the cochlea and the CNS must be carefully addressed in safety studies prior to their clinical application.
28
Finally, these results may have application for other neural prostheses. There is considerable interest in combining knowledge from both functional ES and neural protection/regeneration studies in order to provide improved therapeutic outcomes via neural prostheses (Grill et al., 2001) . 
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